Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Breast 1

Conditions

Myelodysplastic Syndromes 522Leukemia, Myeloid, Acute 404Leukemia, Myelogenous, Chronic, BCR-ABL Positive 308Leukemia 292Precursor Cell Lymphoblastic Leukemia-Lymphoma 234Myeloproliferative Disorders 210Lymphoma, Non-Hodgkin 167Leukemia, Myelomonocytic, Chronic 156Leukemia, Lymphocytic, Chronic, B-Cell 147Hodgkin Disease 142Primary Myelofibrosis 141Multiple Myeloma 133Leukemia, Myeloid, Chronic-Phase 133Lymphoma 114Leukemia, Myeloid, Accelerated Phase 96Blast Crisis 94Anemia, Refractory, with Excess of Blasts 89Polycythemia Vera 88Lymphoma, Follicular 84Burkitt Lymphoma 81Lymphoma, Mantle-Cell 80Myelodysplastic-Myeloproliferative Diseases 78Lymphoma, B-Cell, Marginal Zone 77Lymphoma, Large B-Cell, Diffuse 73Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 70Congenital Abnormalities 70Neoplasms, Plasma Cell 59Lymphoma, Large-Cell, Immunoblastic 59Thrombocythemia, Essential 57Graft vs Host Disease 57

Interventions

Cyproheptadine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Body Weight Changes × Myeloid × Clear all
NCT00949117 2014-04-02

Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

University of South Florida

Phase 2 Terminated
9 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Body Weight Changes, Burkitt Lymphoma, Leukemia, Lymphoma, Myelodysplastic Syndromes, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Malnutrition, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡